Related Experiment Video

Updated: Nov 27, 2025

Assaying the Kinase Activity of LRRK2 in vitro
06:09

Assaying the Kinase Activity of LRRK2 in vitro

Published on: January 18, 2012

22.8K

Pathological Functions of LRRK2 in Parkinson's Disease

Ga Ram Jeong1, Byoung Dae Lee1,2

  • 1Department of Neuroscience, Kyung Hee University, Seoul 02447, Korea.

Cells
|December 3, 2020
PubMed

Insights

Mutations in leucine-rich repeat kinase 2 (LRRK2) are key Parkinson's disease (PD) risk factors. This review explores how LRRK2 mutations disrupt cellular functions and contribute to neurodegeneration in PD.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Mutations in leucine-rich repeat kinase 2 (LRRK2) are significant genetic risk factors for Parkinson's disease (PD).
  • Increased LRRK2 kinase activity is implicated in PD pathogenesis.
  • The exact molecular mechanisms linking LRRK2 to PD pathology are still under investigation.

Purpose of the Study:

  • To summarize current knowledge on how pathogenic LRRK2 mutations dysregulate the protein.
  • To discuss potential mechanisms by which LRRK2 dysfunction leads to neurodegeneration.
  • To highlight LRRK2's role in cellular processes relevant to PD.

Main Methods:

  • Review of existing literature on LRRK2 mutations and Parkinson's disease.
  • Analysis of studies identifying LRRK2 substrates and cellular pathways.
  • Examination of evidence from cellular and animal models.

Main Results:

  • Pathogenic LRRK2 mutations alter kinase activity, contributing to PD.
  • LRRK2 is involved in regulating microtubule dynamics, vesicular trafficking, and synaptic transmission.
  • LRRK2 plays a role in the aggregation and propagation of alpha-synuclein (α-synuclein).

Conclusions:

  • Dysregulated LRRK2 kinase activity due to mutations is a key factor in PD.
  • Understanding LRRK2's cellular functions and its link to α-synuclein is crucial for developing PD therapies.
  • Further research is needed to fully elucidate the neurodegenerative mechanisms driven by LRRK2.
Keywords:
LRRK2Lewy bodyParkinson’s diseaseneurodegenerationα-synuclein

More Related Videos

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate11:31

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate

Published on: September 18, 2013

10.3K
Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag08:55

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Published on: December 14, 2017

15.7K

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.3K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.2K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
770
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
42.3K